Literature DB >> 32240734

TCR-like domain antibody against Mycobacterium tuberculosis (Mtb) heat shock protein antigen presented by HLA-A*11 and HLA-A*24.

Sylvia Annabel Dass1, Mohd Nor Norazmi2, Armando Acosta2, Maria E Sarmiento2, Gee Jun Tye3.   

Abstract

T cell receptor (TCR)-like antibodies, obtained with the use of phage display technology, sandwich the best of the both arms of the adaptive immune system. In this study, in vitro selections against the latency associated Mycobacterium tuberculosis (Mtb) heat shock protein 16 kDa antigen (16 kDa) presented by HLA-A*011 and HLA-A*24 were carried out with the use of a human domain phage antibody library. TCR-like domain antibodies (A11Ab and A24Ab) were successfully generated recognizing 16 kDa epitopes presented by HLA-A*011 and HLA-A*24 molecules respectively. Both antibodies were found to be functional in soluble form and exhibited strong binding capacity against its targets. The results obtained support the future evaluation of these ligands for the development of diagnostic and therapeutic tools for tuberculosis infection.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody phage display; Diagnostics; Immunotherapy; Latent tuberculosis; T cell receptor (TCR)-like antibody

Mesh:

Substances:

Year:  2020        PMID: 32240734     DOI: 10.1016/j.ijbiomac.2020.03.229

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

Review 1.  The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.

Authors:  Sylvia Annabel Dass; Rehasri Selva Rajan; Gee Jun Tye; Venugopal Balakrishnan
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

2.  A Direct Role for the CD1b Endogenous Spacer in the Recognition of a Mycobacterium tuberculosis Antigen by T-Cell Receptors.

Authors:  Frank Camacho; Ernesto Moreno; Luis F Garcia-Alles; Glay Chinea Santiago; Martine Gilleron; Aleikar Vasquez; Yee Siew Choong; Fátima Reyes; Mohd Nor Norazmi; Maria E Sarmiento; Armando Acosta
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 3.  The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.

Authors:  Sylvia Annabel Dass; Venugopal Balakrishnan; Norsyahida Arifin; Crystale Siew Ying Lim; Fazlina Nordin; Gee Jun Tye
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

4.  Role of antibodies in vaccine-mediated protection against tuberculosis.

Authors:  Francesco Dieli; Juraj Ivanyi
Journal:  Cell Mol Immunol       Date:  2022-04-08       Impact factor: 22.096

Review 5.  Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.

Authors:  Lichen Zhu; Xiaomei Yang; Dani Zhong; Shenxia Xie; Wei Shi; Yangzi Li; Xiaoqiong Hou; Huihui Zhou; Minlong Zhao; Ziqiang Ding; Xinyue Zhao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  J Immunol Res       Date:  2020-09-07       Impact factor: 4.818

6.  Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen.

Authors:  Paola A Ortega; Mayra Silva-Miranda; Alfredo Torres-Larios; Eduardo Campos-Chávez; Kees C L C M Franken; Tom H M Ottenhoff; Juraj Ivanyi; Clara Espitia
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.